project id: TCGA-SKCM; case submitter id: TCGA-FS-A4F5; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.8; age at index: 77; days to birth: -28412; days to death: 874; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1928; year of death: 2007; age at diagnosis: 28412; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C49.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 30.0; oct embedded: false; preservation method: Unknown; sample id: 881cfcc8-bfcf-4404-8742-5be9be653412; sample submitter id: TCGA-FS-A4F5-06A; portion id: c9c54aa0-b998-4939-8de6-66a30603cadf; portion submitter id: TCGA-FS-A4F5-06A-11; slide id: e1681485-57cb-4102-8b6f-94c411270651; slide submitter id: TCGA-FS-A4F5-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 88.0; section location: TOP;